Literature DB >> 21255204

TB and HIV integration: obstacles and possible solutions to implementation in South Africa.

Marian Loveday1, Virginia Zweigenthal.   

Abstract

OBJECTIVES: To identify key obstacles to operational integration of TB and HIV services and to suggest strategies to promote integration in the prevention, treatment and care of patients with TB and HIV.
METHODS: This is a health systems research case study of operational integration of TB and HIV in South Africa. Peer-reviewed and grey literature together with the experiences of the authors were used to identify key obstacles to integration in service implementation practices and community-level care. Relevant legislation, policies and guidelines were analysed to determine whether they facilitated or undermined the integration of TB and HIV services.
RESULTS: Obstacles to integration exist at contextual and epidemiological levels as well as at intervention design and implementation levels. Importantly, integration at an operational level is undermined by fundamentally different principles underpinning the design of TB and HIV programmes and national policies and legislation which mitigate against integration.
CONCLUSION: South Africa has an opportunity to effect changes that will facilitate TB/HIV integration and improve care for all those infected with TB, HIV or both conditions. An analytic approach necessary to understand the obstacles to and ensure effective strategies facilitating integration is required. This needs to be followed by mobilisation of clinical and health systems expertise, health infrastructure, commitment and experience in creative and appropriate ways for the variety of health care settings.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21255204     DOI: 10.1111/j.1365-3156.2010.02721.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  16 in total

1.  TB/HIV integration at primary care level: A quantitative assessment at 3 clinics in Johannesburg, South Africa.

Authors:  L Page-Shipp; Y Voss De Lima; K Clouse; J de Vos; L Evarts; J Bassett; I Sanne; A Van Rie
Journal:  South Afr J HIV Med       Date:  2012-09       Impact factor: 2.744

2.  Tuberculosis drug development: ensuring people living with HIV are not left behind.

Authors:  Anne F Luetkemeyer; Haileyesus Getahun; Gabriel Chamie; Christian Lienhardt; Diane V Havlir
Journal:  Am J Respir Crit Care Med       Date:  2011-08-25       Impact factor: 21.405

3.  Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa.

Authors:  Kogieleum Naidoo; Anneke C Grobler; Nicola Deghaye; Tarylee Reddy; Santhanalakshmi Gengiah; Andrew Gray; Salim Abdool Karim
Journal:  J Acquir Immune Defic Syndr       Date:  2015-08-15       Impact factor: 3.731

4.  Timing of antiretroviral therapy in Cambodian hospital after diagnosis of tuberculosis: impact of revised WHO guidelines.

Authors:  Kimcheng Choun; Reaksmey Pe; Sopheak Thai; Natalie Lorent; Lutgarde Lynen; Johan van Griensven
Journal:  Bull World Health Organ       Date:  2012-12-12       Impact factor: 9.408

5.  Effect of TB/HIV Integration on TB and HIV Indicators in Rural Ugandan Health Facilities.

Authors:  Sarah M Burnett; Stella Zawedde-Muyanja; Sabine M Hermans; Marcia R Weaver; Robert Colebunders; Yukari C Manabe
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-15       Impact factor: 3.731

6.  Improving data quality and supervision of antiretroviral therapy sites in Malawi: an application of Lot Quality Assurance Sampling.

Authors:  Bethany L Hedt-Gauthier; Lyson Tenthani; Shira Mitchell; Frank M Chimbwandira; Simon Makombe; Zengani Chirwa; Erik J Schouten; Marcello Pagano; Andreas Jahn
Journal:  BMC Health Serv Res       Date:  2012-07-09       Impact factor: 2.655

7.  Association between health systems performance and treatment outcomes in patients co-infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: implications for TB programmes.

Authors:  Marian Loveday; Nesri Padayatchi; Kristina Wallengren; Jacquelin Roberts; James C M Brust; Jacqueline Ngozo; Iqbal Master; Anna Voce
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

8.  Current integration of tuberculosis (TB) and HIV services in South Africa, 2011.

Authors:  Joel C Chehab; Amanda K Vilakazi-Nhlapo; Peter Vranken; Annatjie Peters; Jeffrey D Klausner
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

9.  A pilot study of an mHealth application for healthcare workers: poor uptake despite high reported acceptability at a rural South African community-based MDR-TB treatment program.

Authors:  Krisda H Chaiyachati; Marian Loveday; Stephen Lorenz; Neal Lesh; Lee-Megan Larkan; Sandro Cinti; Gerald H Friedland; Jessica E Haberer
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

10.  Delayed initiation of anti-retroviral therapy in TB/HIV co-infected patients, Sanyati District, Zimbabwe, 2011-2012.

Authors:  Brian Abel Maponga; Daniel Chirundu; Notion Tafara Gombe; Mufuta Tshimanga; Donewell Bangure; Lucia Takundwa
Journal:  Pan Afr Med J       Date:  2015-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.